What is Tigecycline and Its Associated Diarrhea?
Tigecycline is a broad-spectrum antibiotic used to treat various bacterial infections. Like many antibiotics, it can disrupt the balance of gut bacteria, leading to side effects such as diarrhea [1]. The exact cause of tigecycline-associated diarrhea is not fully understood, but it is thought to be related to changes in the bacterial composition of the gut.
What is the Current State of Probiotics in Preventing Diarrhea?
Probiotics are live microorganisms that provide health benefits when consumed, generally by improving or restoring the gut flora. Research has explored the potential of probiotics in preventing tigecycline-associated diarrhea [2]. However, results are mixed, and more studies are needed to fully understand their effectiveness.
Why Are Companies Developing Alternative Solutions?
Companies are challenging this patent because the current market for probiotics is competitive and constantly evolving. Pharmaceutical companies are developing alternative solutions, such as prebiotics, synbiotics, and new-generation probiotics, to address the issue of antibiotic-associated diarrhea [3].
How Do Probiotics Compare to Other Solutions?
Probiotics are not always the most effective solution in preventing antibiotic-associated diarrhea. In some cases, other solutions like prebiotics or synbiotics (combinations of probiotics and prebiotics) may be more effective [4]. Research is ongoing to compare the effectiveness of various solutions.
What Side Effects Should Patients be Aware of?
When taking probiotics, patients should be aware of potential side effects, such as bloating, gas, or allergic reactions [5]. In severe cases, patients should consult their healthcare provider if they experience persistent diarrhea or other symptoms.
Can Biosimilars Enter the Market Before Patent Expiry?
While biosimilars are not directly related to tigecycline-associated diarrhea, the patent expiry timeline for probiotics and their manufacturing processes will impact the development of biosimilar versions of these supplements.
When Does Exclusivity Expire?
The exclusivity for tigecycline-associated diarrhea treatments and probiotics will expire in the future. This will allow generic and biosimilar versions of these products to enter the market, increasing competition and potentially making them more affordable.
Sources:
[1] https://www.ncbi.nlm.nih.gov/pubmed/16951151
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751425/
[3] https://www.drugpatentwatch.com/ DrugPatentWatch.com provides information on pharmaceutical patents and their expiry dates.
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424444/
[5] https://www.ncbi.nlm.nih.gov/pubmed/24425519